Life-Threatening Macrophage Activation Syndrome as the Initial Presentation of Systemic Lupus Erythematosus: A Case Report and Review of the Literature

    November 2022 in “ The Egyptian Rheumatologist
    Samar Tharwat, Heba Wagih Abdelwahab, M. G. Abdelzaher, Leila Bakr, Aya El Hassany, Mostafa Abdelsattar, Rehab T. Eldesoky, Eman Ibrahim
    TLDR Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.
    This case report and literature review discuss a rare and fatal initial presentation of systemic lupus erythematosus (SLE) with macrophage activation syndrome (MAS) in a 20-year-old female. The patient experienced persistent fever, significant weight loss, and hematologic abnormalities, and despite aggressive treatment, the MAS was fatal. The report highlights the diagnostic challenges and high mortality of MAS in SLE patients, stressing the need for early recognition and intervention. The review of literature underscores the rarity and critical importance of prompt treatment for MAS in the context of SLE.
    Discuss this study in the Community →

    Related Community Posts Join

    3 / 3 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Verteporfin and Microneedling

      in Treatments 6 months ago
      Clinical studies by Dr. Barghouthi and Dr. Bloxham indicate that Verteporfin, when used with FUE and FUT hair transplantation methods, shows promise in hair follicle regeneration and minimal scarring due to its ability to inhibit Yes-associated protein (YAP). Microneedling at depths of 3-3.5mm, combined with Verteporfin, could potentially reactivate dormant follicles, although the optimal dosage and application method are still under investigation. Concerns remain about the DHT sensitivity of regenerated follicles, highlighting the need for further research to optimize trauma levels and Verteporfin concentrations to achieve effective and scar-free hair regeneration.

      community The Worst Hair Loss Condition You (MAY) have: LPP

      in Research/Science  43 upvotes 3 months ago
      Lichen Planopilaris (LPP) is an autoimmune condition causing permanent hair loss and fibrosis, often misdiagnosed. Treatments include pioglitazone, topical corticosteroids, anti-inflammatory medication, and Jak inhibitors.

    Similar Research

    5 / 1000+ results